BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16085594)

  • 1. Clinically significant incidental findings on the unenhanced CT portion of PET/CT studies: frequency in 250 patients.
    Osman MM; Cohade C; Fishman EK; Wahl RL
    J Nucl Med; 2005 Aug; 46(8):1352-5. PubMed ID: 16085594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT in PET/CT: essential features of interpretation.
    Schöder H; Yeung HW; Larson SM
    J Nucl Med; 2005 Aug; 46(8):1249-51. PubMed ID: 16085577
    [No Abstract]   [Full Text] [Related]  

  • 3. Limitations of CT during PET/CT.
    Gollub MJ; Hong R; Sarasohn DM; Akhurst T
    J Nucl Med; 2007 Oct; 48(10):1583-91. PubMed ID: 17873133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Objective and subjective comparison of standard 2-D and fully 3-D reconstructed data on a PET/CT system.
    Strobel K; Rüdy M; Treyer V; Veit-Haibach P; Burger C; Hany TF
    Nucl Med Commun; 2007 Jul; 28(7):555-9. PubMed ID: 17538397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep-inspiration breath-hold PET/CT: clinical findings with a new technique for detection and characterization of thoracic lesions.
    Meirelles GS; Erdi YE; Nehmeh SA; Squire OD; Larson SM; Humm JL; Schöder H
    J Nucl Med; 2007 May; 48(5):712-9. PubMed ID: 17475958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
    Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F
    Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data.
    Martinez-Möller A; Souvatzoglou M; Delso G; Bundschuh RA; Chefd'hotel C; Ziegler SI; Navab N; Schwaiger M; Nekolla SG
    J Nucl Med; 2009 Apr; 50(4):520-6. PubMed ID: 19289430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer.
    Anjos DA; Etchebehere EC; Ramos CD; Santos AO; Albertotti C; Camargo EE
    J Nucl Med; 2007 May; 48(5):764-70. PubMed ID: 17475965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of a breath-holding acquisition method in PET/CT for pulmonary lesions.
    Yamaguchi T; Ueda O; Hara H; Sakai H; Kida T; Suzuki K; Adachi S; Ishii K
    Ann Nucl Med; 2009 Jan; 23(1):65-71. PubMed ID: 19205840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation correction of PET images with respiration-averaged CT images in PET/CT.
    Pan T; Mawlawi O; Nehmeh SA; Erdi YE; Luo D; Liu HH; Castillo R; Mohan R; Liao Z; Macapinlac HA
    J Nucl Med; 2005 Sep; 46(9):1481-7. PubMed ID: 16157531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of myocardial perfusion 82Rb PET performed with CT- and transmission CT-based attenuation correction.
    Slomka PJ; Le Meunier L; Hayes SW; Acampa W; Oba M; Haemer GG; Berman DS; Germano G
    J Nucl Med; 2008 Dec; 49(12):1992-8. PubMed ID: 19038996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDOPA PET and PET/CT accurately localize pheochromocytomas.
    Imani F; Agopian VG; Auerbach MS; Walter MA; Imani F; Benz MR; Dumont RA; Lai CK; Czernin JG; Yeh MW
    J Nucl Med; 2009 Apr; 50(4):513-9. PubMed ID: 19289420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusion of PET and CT images using wavelet transform.
    Shalchian B; Rajabi H; Soltanian-zadeh H
    Hell J Nucl Med; 2009; 12(3):238-43. PubMed ID: 19936335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidental PET/CT findings in the cancer patient: how should they be managed?
    Beatty JS; Williams HT; Aldridge BA; Hughes MP; Vasudeva VS; Gucwa AL; David GS; Lind DS; Kruse EJ; McLoughlin JM
    Surgery; 2009 Aug; 146(2):274-81. PubMed ID: 19628085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved attenuation correction via appropriate selection of respiratory-correlated PET data.
    Daouk J; Fin L; Bailly P; Meyer ME
    Comput Methods Programs Biomed; 2008 Oct; 92(1):90-8. PubMed ID: 18676054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine neoplasm scintigraphy: added value of fusing SPECT/CT images compared with traditional side-by-side analysis.
    Ingui CJ; Shah NP; Oates ME
    Clin Nucl Med; 2006 Nov; 31(11):665-72. PubMed ID: 17053381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staging pathways in recurrent colorectal carcinoma: is contrast-enhanced 18F-FDG PET/CT the diagnostic tool of choice?
    Soyka JD; Veit-Haibach P; Strobel K; Breitenstein S; Tschopp A; Mende KA; Lago MP; Hany TF
    J Nucl Med; 2008 Mar; 49(3):354-61. PubMed ID: 18287263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated 3-dimensional elastic registration of whole-body PET and CT from separate or combined scanners.
    Shekhar R; Walimbe V; Raja S; Zagrodsky V; Kanvinde M; Wu G; Bybel B
    J Nucl Med; 2005 Sep; 46(9):1488-96. PubMed ID: 16157532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin.
    Zhang M; Jiang X; Zhang M; Xu H; Zhai G; Li B
    J Nucl Med; 2009 Apr; 50(4):506-12. PubMed ID: 19289438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized contrast-enhanced CT protocols for diagnostic whole-body 18F-FDG PET/CT: technical aspects of single-phase versus multiphase CT imaging.
    Brechtel K; Klein M; Vogel M; Mueller M; Aschoff P; Beyer T; Eschmann SM; Bares R; Claussen CD; Pfannenberg AC
    J Nucl Med; 2006 Mar; 47(3):470-6. PubMed ID: 16513616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.